Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-03-21 @ 2:44 PM
Study NCT ID:
NCT04728802
Status:
COMPLETED
Last Update Posted:
2021-06-24
First Post:
2021-01-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Proxalutamide Treatment for Hospitalized COVID-19 Patients
Sponsor:
Applied Biology, Inc.
Organization:
Study Overview
Official Title:
Proxalutamide Treatment for Hospitalized COVID-19 Patients
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy and safety of Proxalutamide as a treatment for hospitalized COVID-19 male and female patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: